HEALTH NEWS
Study Title:
Waist-to-height ratio as an indicator of 'early health risk': simpler and more predictive than using a 'matrix' based on BMI and waist circumference.
Study Abstract
OBJECTIVES:
There is now good evidence that central obesity carries more health risks compared with total obesity assessed by body mass index (BMI). It has therefore been suggested that waist circumference (WC), a proxy for central obesity, should be included with BMI in a 'matrix' to categorise health risk. We wanted to compare how the adult UK population is classified using such a 'matrix' with that using another proxy for central obesity, waist-to-height ratio (WHtR), using a boundary value of 0.5. Further, we wished to compare cardiometabolic risk factors in adults with 'healthy' BMI divided according to whether they have WHtR below or above 0.5.
SETTING, PARTICIPANTS AND OUTCOME MEASURES:
Recent data from 4 years (2008-2012) of the UK National Diet and Nutrition Survey (NDNS) (n=1453 adults) were used to cross-classify respondents on anthropometric indices. Regression was used to examine differences in levels of risk factors (triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), TC: HDL, glycated haemoglobin (HbA1c), fasting glucose, systolic (SBP) and diastolic blood pressure (DBP)) according to WHtR below and above 0.5, with adjustment for confounders (age, sex and BMI).
RESULTS:
35% of the group who were judged to be at 'no increased risk' using the 'matrix' had WHtR ≥ 0.5. The 'matrix' did not assign 'increased risk' to those with a 'healthy' BMI and 'high' waist circumference. However, our analysis showed that the group with 'healthy' BMI, and WHtR ≥ 0.5, had some significantly higher cardiometabolic risk factors compared to the group with 'healthy' BMI but WHtR below 0.5.
CONCLUSIONS:
Use of a simple boundary value for WHtR (0.5) identifies more people at 'early health risk' than does a more complex 'matrix' using traditional boundary values for BMI and WC. WHtR may be a simpler and more predictive indicator of the 'early heath risks' associated with central obesity.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Study Information
BMJ Open. 2016 Mar 14;6(3):e010159. doi: 10.1136/bmjopen-2015-010159.Full Study
https://www.ncbi.nlm.nih.gov/pubmed/26975935Recent News
Arabinogalactan Boosts Lymph Flow and Immunity
Protect Your Gut Mucosal Barrier for Immune Health and Vitality
The Truth About Sugar Substitutes: Are Stevia, Sucralose, and Saccharin Safe?
Boost Your Digestive Power for Better Nutrient Absorption and Gut Health
MTHFR Gene and The Importance of Methyl B12 and Methyl Folate